IceCure Medical Expands ChoICE Study for Breast Cancer
Caesarea, Israel, August 7, 2026 IceCure Medical has announced a significant expansion of its U.S. post-marketing clinical program with...
Premature Ventricular Complexes
Advertisement
Ractigen Advances Phase II Trial of RAG-17 for SOD1-ALS
Nantong, China, August 7, 2026 Ractigen Therapeutics has announced a significant milestone in the development of its investigational RNA...
Reckitt Secures FDA Approval for New Mucinex 12HR Therapy
Nutley, New Jersey, USA, August 5, 2026 Reckitt has received U.S. Food and Drug Administration (FDA) approval for Mucinex®...
Medtronic Expands CE Mark for Sphere-9 in Ventricular Ablation
Galway, Ireland, August 6, 2026 Medtronic has secured an expanded CE Mark indication for its Affera™ Mapping and Ablation...
Advertisement
